Skip to main content
Log in

Anakinra delayed skin allergy expressing as both injection site reactions and generalized exanthema

  • Correspondence
  • Published:
European Journal of Dermatology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fleischmann RM, Schechtman J, Bennett R, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial. Arthritis Rheum 2003; 48: 927–34.

    Article  PubMed  CAS  Google Scholar 

  2. Furst DE. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther 2004; 26: 1960–75.

    Article  PubMed  CAS  Google Scholar 

  3. Nosbaum A, Pralong P, Rozières A, Dargaud Y, Nicolas JF, Bérard F. Delayed-type hypersensitivity to heparin: diagnosis and therapeutic management. Ann Dermatol Venereol 2012; 139: 363–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elena R. Lungoci.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lungoci, E.R., Hacard, F., Nicolas, JF. et al. Anakinra delayed skin allergy expressing as both injection site reactions and generalized exanthema. Eur J Dermatol 25, 503–504 (2015). https://doi.org/10.1684/ejd.2015.2624

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2015.2624

Keywords

Navigation